Class Attys Want $39M Cut Of $105M Lidoderm Settlement
Attorneys for end-payors who claimed that pharmaceutical companies delayed the release of a generic form of the Lidoderm pain patch have asked a California federal court to award $38.6 million in...To view the full article, register now.
Already a subscriber? Click here to view full article